{{--
  Back to User
--}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) Logout @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
Back

A survey to assess the usage pattern of Fixed dose combination (FDC) Olanzapine + Fluoxetine in the management of Bipolar Depression in India

Survey Questionnaire Form
Doctor’s details
@if(isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of bipolar depression do you see in a month?*

  2. In your clinical practice bipolar depression in commonly found in*

  3. In your clinical experience, bipolar depression is more commonly diagnosed in which age group of patients?*

  4. How often do you encounter bipolar depression cases in your practice?*

  5. In your clinical practice what is / are the most common cause/ causes of bipolar depression?*
  6. In your clinical practice which scale do you prefer for screening the patient for bipolar depression?*
  7. In your clinical practice which of the following guidelines do you primarily use for the management of bipolar depression?*

  8. Which is your preferred choice of drug for treatment of bipolar depression?*
  9. Do you prescribe FDC of olanzapine and fluoxetine combination for bipolar depression?*

  10. As per your clinical experience, which factors are critical for choosing first-line treatment option in the management of bipolar depression?*

  11. Have you prescribed FDC of olanzapine -fluoxetine for managing bipolar depression in the past 1 month?*

  12. What percentage of your bipolar depressed patients currently take FDC of olanzapine -fluoxetine?*

  13. What is the typical starting dose of FDC of olanzapine -fluoxetine you prescribe for adult patients with depression?*

  14. How often do you adjust the dosage of FDC of olanzapine -fluoxetine during treatment?*

  15. How do you assess disease progression and treatment response in patients of bipolar depression?*

  16. In your experience, how long does it usually take for patients to experience symptom improvement with FDC of olanzapine -fluoxetine? *

  17. What factors influence your decision to prescribe FDC of olanzapine -fluoxetine in bipolar depression?*

  18. How often do you schedule follow-up appointments with patients after initiating FDC of olanzapine -fluoxetine treatment?*

  19. Do you recommend lifestyle modifications in conjunction with FDC of olanzapine-fluoxetine treatment?*

  20. What strategies do you use to enhance patient adherence to FDC of olanzapine -fluoxetine therapy?*

  21. In your clinical practice do you prescribe FDC of olanzapine -fluoxetine in bipolar depression patients with comorbidities?*

  22. Based on your clinical experience, knowledge and practice, what are the potential reasons for choosing FDC of olanzapine -fluoxetine? *
  23. In your experience, how effective is FDC of olanzapine -fluoxetine in reducing bipolar depression?*

  24. In your opinion what are the factors which most commonly contribute to medication non-adherence in bipolar depression patients?*
  25. What percentage of your patients report satisfactory compliance with FDC of olanzapine -fluoxetine treatment?*

  26. Mention some initial instructions/advice you give to your patients before initiating the FDC of olanzapine -fluoxetine for the treatment of bipolar depression?*
  27. What is your opinion on long-term FDC of olanzapine + fluoxetine for maintenance therapy in bipolar depression?*
  28. What is the most significant challenge you face in managing bipolar depression patients?*
  29. In your opinion, what advantage does FDC of olanzapine - fluoxetine offer over existing therapies for bipolar depression?*
  30. What are your thoughts on the efficacy and overall tolerability of FDC of olanzapine - fluoxetine compared to other antidepressant in the management of bipolar depression?*